🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆
Updated 21 Aug 2026 · ClinicalTrials.gov

Clinical Trials in Arkansas

← All US trials

The most recently updated industry-sponsored clinical trials recruiting across the United States — searchable by condition, sponsor, phase and state. Refreshed daily from the ClinicalTrials.gov registry.

19
Recruiting now
23
Studies tracked
Arkansas
Selected state
Recruiting Phase 2
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Merck Sharp & Dohme LLC · started 2025-04-11
📍 Alabama · Arizona · Arkansas · California · Colorado · Delaware · District of Columbia · Florida
NCT06890884 on ClinicalTrials.gov ↗
Active Phase 3
Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury
Lower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain Injury
Merz Pharmaceuticals GmbH · started 2019-09-16
📍 Alabama · Arkansas · California · Connecticut · Florida · Massachusetts · Missouri · New York
NCT03992404 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
Smoking
Eli Lilly and Company · started 2025-11-03
📍 Arkansas · Florida · Georgia · Michigan · Missouri · Nevada · New York · South Carolina
NCT07223840 on ClinicalTrials.gov ↗
Active Phase 2
Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)
Overweight, Type 2 Diabetes, Obesity
Zealand Pharma · started 2025-04-22
📍 Alabama · Arizona · Arkansas · California · Connecticut · District of Columbia · Florida · Georgia
NCT06926842 on ClinicalTrials.gov ↗
Active Phase 3
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa
AbbVie · started 2024-06-27
📍 Alabama · Arizona · Arkansas · California · Connecticut · Florida · Georgia · Idaho
NCT06468228 on ClinicalTrials.gov ↗
Recruiting Phase 2
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Glioblastoma (GBM), Newly Diagnosed Glioblastoma, GBM, Glioblastoma Multiforme (GBM)
Black Diamond Therapeutics, Inc. · started 2026-05-05
📍 Alabama · Arkansas · California · Connecticut · District of Columbia · Florida · Maryland · Massachusetts
NCT07326566 on ClinicalTrials.gov ↗
Recruiting Phase 2
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
Hematologic Malignancies, Waldenstroms Macroglobulinaemia, Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia
Merck Sharp & Dohme LLC · started 2021-04-05
📍 Arkansas · California · Colorado · Kentucky · Minnesota · New Jersey · North Dakota · Texas
NCT04728893 on ClinicalTrials.gov ↗
Recruiting Phase 3
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
Lennox Gastaut Syndrome
Epygenix · started 2025-04-09
📍 Arkansas · California · Florida · Illinois · Kentucky · Michigan · Minnesota · Nebraska
NCT05066217 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Episodic Migraine
AbbVie · started 2023-05-01
📍 Alabama · Arkansas · California · Colorado · Florida · Georgia · Indiana · Kansas
NCT05711394 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Eli Lilly and Company · started 2025-10-15
📍 Alabama · Arizona · Arkansas · California · Colorado · Connecticut · Florida · Georgia
NCT07165028 on ClinicalTrials.gov ↗
Recruiting Phase 3
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Early Breast Cancer
Novartis Pharmaceuticals · started 2024-02-28
📍 Alabama · Alaska · Arizona · Arkansas · California · Colorado · District of Columbia · Florida
NCT05827081 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
Schizophrenia
Leal Therapeutics, Inc · started 2026-08
📍 Arkansas · California · Florida · Georgia · Maryland · New Jersey · Texas
NCT07734493 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
Myelodysplastic Syndromes, Cytopenia
Takeda · started 2020-08-19
📍 Arkansas · California · Florida · Maryland · Michigan · New Jersey · New York · Pennsylvania
NCT04419649 on ClinicalTrials.gov ↗
Recruiting Phase 2
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
AstraZeneca · started 2022-04-14
📍 Arkansas · California · Connecticut · Florida · Georgia · Illinois · Maryland · Massachusetts
NCT05061550 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Brenipatide in Participants With Alcohol Use Disorder
Alcohol Use Disorder
Eli Lilly and Company · started 2025-10-16
📍 Arizona · Arkansas · California · Florida · Illinois · Maryland · Massachusetts · New York
NCT07219953 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study of Brenipatide in Participants With Opioid Use Disorder
Opioid Use Disorder
Eli Lilly and Company · started 2026-02-13
📍 Arizona · Arkansas · California · Florida · Illinois · Indiana · Kentucky · Maryland
NCT07420283 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
Eli Lilly and Company · started 2025-12-12
📍 Alabama · Arizona · Arkansas · California · Colorado · Connecticut · District of Columbia · Florida
NCT07218380 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
Endometrial Adenocarcinoma
Acrivon Therapeutics · started 2022-08-29
📍 Alabama · Alaska · Arizona · Arkansas · California · Colorado · Connecticut · Florida
NCT05548296 on ClinicalTrials.gov ↗
Recruiting Phase 3
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Cardiovascular Disease
Amgen · started 2025-08-22
📍 Alabama · Arizona · Arkansas · California · Colorado · Connecticut · Florida · Georgia
NCT07136012 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Non Small Cell Lung Cancer
Merck Sharp & Dohme LLC · started 2024-04-03
📍 Arkansas · California · Connecticut · Florida · Georgia · Illinois · Indiana · Kentucky
NCT06312137 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma, Lymphoma, Small Lymphocytic
Merck Sharp & Dohme LLC · started 2023-08-08
📍 Arkansas · California · Florida · Indiana · Maryland · Mississippi · Missouri · Montana
NCT05947851 on ClinicalTrials.gov ↗
Recruiting Phase 3
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Migraine
AbbVie · started 2022-01-13
📍 Alabama · Arizona · Arkansas · California · Colorado · Connecticut · District of Columbia · Florida
NCT05125302 on ClinicalTrials.gov ↗
Active Phase 2
A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis
Moderate to Severe Atopic Dermatitis
Nektar Therapeutics · started 2023-11-15
📍 Arkansas · California · Florida · Georgia · Indiana · Kentucky · Michigan · Nevada
NCT06136741 on ClinicalTrials.gov ↗
No trials match your search.

Browse by state

California · 112 Florida · 111 Georgia · 60 Colorado · 54 Arizona · 53 Illinois · 48 New York · 44 Massachusetts · 41 Connecticut · 38 Alabama · 37 Michigan · 30 Indiana · 27 Maryland · 27 Ohio · 26 Arkansas · 23 Kentucky · 21

Browse by condition

Prostate Cancer · 5 Ovarian Cancer · 4 Overweight · 4 Obesity · 4 Systemic Lupus Erythematosus · 3 Ulcerative Colitis · 3 Follicular Lymphoma · 3 Heart Failure · 3 Non-small Cell Lung Cancer · 3 Lymphoma, Large B-Cell, Diffuse · 2 Diabetes Mellitus, Type 1 · 2 Breast Neoplasms · 2 B-cell Malignancy · 2 Hidradenitis Suppurativa · 2 Acute Myeloid Leukemia · 2 Ovarian Neoplasms · 2
Cite this page

Priya Life Science (2026). Clinical Trials in the USA Tracker. Available at: https://priyalifescience.com/clinical-trials-usa/state/arkansas (Accessed: 22 August 2026).

Embed this data ↗

Source: ClinicalTrials.gov, U.S. National Library of Medicine — industry-sponsored studies in a recruiting status with at least one US site, most recently updated first, refreshed daily. This is a curated slice of the full registry, not every US trial. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. Compare pay for the teams running these studies in our US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish and EU sites, see our Ireland and EU trackers.